Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 57.60M | $ 61.30M | $ 97.80M | $ 60.80M | $ 144.80M |
Total Assets | $ 2.04B | $ 1.95B | $ 1.99B | $ 1.97B | $ 2.00B |
Total Debt | $ 755.30M | $ 667.60M | $ 748.70M | $ 736.90M | $ 811.70M |
Net Debt | $ 697.70M | $ 606.30M | $ 650.90M | $ 676.10M | $ 666.90M |
Total Liabilities | $ 1.69B | $ 1.61B | $ 1.69B | $ 1.73B | $ 1.77B |
Stockholders Equity | $ 338.90M | $ 331.20M | $ 286.80M | $ 231.50M | $ 225.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |